<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Moreover, CDs like HP-β-CD and SBE-β-CD are considered safe for parenteral administration and are commonly used with antitumor and immunomodulatory drugs [
 <xref rid="B21-ijms-20-00642" ref-type="bibr" class="xref">21</xref>,
 <xref rid="B22-ijms-20-00642" ref-type="bibr" class="xref">22</xref>,
 <xref rid="B23-ijms-20-00642" ref-type="bibr" class="xref">23</xref>]. Recently the Food and Drug Administration (FDA) approved pharmaceutical formulations containing liposomal preparations of doxorubicin (Doxil), daunorubicin (DaunoXome), cytarabine (DepoCyt), and amphotericin B (Abelcet), which have proven to be attractive and less toxic alternatives to the conventional drug formulations [
 <xref rid="B19-ijms-20-00642" ref-type="bibr" class="xref">19</xref>]. Therefore, CDs are well tolerated, atoxic if used in safe concentration ranges already well-described in the literature and considered safe for complexion with drugs.
</p>
